BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19095988)

  • 1. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
    Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
    Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating endothelial progenitor cells in septic patients: correlation with survival.
    Rafat N; Hanusch C; Brinkkoetter PT; Schulte J; Brade J; Zijlstra JG; van der Woude FJ; van Ackern K; Yard BA; Beck GCh
    Crit Care Med; 2007 Jul; 35(7):1677-84. PubMed ID: 17522579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial progenitor cells in malignant gliomas.
    Rafat N; Beck GCh; Schulte J; Tuettenberg J; Vajkoczy P
    J Neurosurg; 2010 Jan; 112(1):43-9. PubMed ID: 19522573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of circulating SDF-1α and CD34+ CXCR4+ cells in patients with moyamoya disease.
    Ni G; Liu W; Huang X; Zhu S; Yue X; Chen Z; Chen M; Liu X; Xu G
    Eur J Neurol; 2011 Nov; 18(11):1304-9. PubMed ID: 21435112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
    Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.
    Zhang W; Wang X; Wang Z; Shang J; Wang H; Yin G
    World Neurosurg; 2016 Sep; 93():365-70. PubMed ID: 27350298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease.
    Kim JH; Jung JH; Phi JH; Kang HS; Kim JE; Chae JH; Kim SJ; Kim YH; Kim YY; Cho BK; Wang KC; Kim SK
    J Neurosci Res; 2010 Feb; 88(3):510-8. PubMed ID: 19774676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
    Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z
    Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.
    Hojo M; Hoshimaru M; Miyamoto S; Taki W; Nagata I; Asahi M; Matsuura N; Ishizaki R; Kikuchi H; Hashimoto N
    J Neurosurg; 1998 Oct; 89(4):623-9. PubMed ID: 9761057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of stromal cell-derived factor-1 (CXCL12) and circulating endothelial progenitor cells in women with idiopathic heavy menstrual bleeding.
    Elsheikh E; Andersson E; Sylvén C; Ericzon BG; Palmblad J; Mints M
    Hum Reprod; 2014 Jan; 29(1):49-56. PubMed ID: 24218400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
    Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
    Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.
    Choi SA; Chong S; Kwak PA; Moon YJ; Jangra A; Phi JH; Lee JY; Park SH; Kim SK
    J Neurosurg Pediatr; 2018 Nov; 23(2):204-213. PubMed ID: 30668528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.
    Tokairin K; Hamauchi S; Ito M; Kazumata K; Sugiyama T; Nakayama N; Kawabori M; Osanai T; Houkin K
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105305. PubMed ID: 32992193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
    Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
    J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model.
    Kang HS; Moon YJ; Kim YY; Park WY; Park AK; Wang KC; Kim JE; Phi JH; Lee JY; Kim SK
    J Neurosurg; 2014 Feb; 120(2):415-25. PubMed ID: 24160477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma.
    Yang B; Gu W; Peng B; Xu Y; Liu M; Che J; Geng J; Zheng J
    J Urol; 2012 Dec; 188(6):2055-61. PubMed ID: 23088990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.